Clinical Trial Update: Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients [Phase 3]

View source ↗

Summary

This document provides an update on the Phase 3 trial of Tyroserleutide for injection in hepatocellular carcinoma patients. The current status of the trial is U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tyroserleutide

Snippet

Sponsor: Shenzhen Kangzhe Pharmaceutical Co., Ltd. | Conditions: Hepatocellular,Carcinoma | Phase 3 | Status: UNKNOWN